PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Stem cell-derived therapy shows promise against treatment-resistant liver cancer

New findings can be applied to NK cells — an under-appreciated part of the immune system — as well as CAR T cells, improving both therapies for multiple solid tumor types

2024-07-09
(Press-News.org) Researchers at University of California San Diego have found that the most common form of liver cancer — one with a high mortality rate — can be better targeted and treated using an innovative new stem cell-derived therapy, according to a recently published study in Cell Stem Cell.

The treatment, not yet studied in patients, involves the lab engineering of natural killer (NK) cells — white blood cells that destroy tumor cells — to more effectively battle hepatocellular carcinoma (HCC), one of the most treatment-resistant types of solid tumor.

Genetically modified NK-cell therapy doesn't require personalization like chimeric antigen receptor (CAR)-expressing T-cell therapy — a relatively new, personalized form of immunotherapy. That means an NK-cell therapy could be mass produced and shelf-ready for patients, who could begin therapy without delay, their new research shows.

“To some extent all tumor cells — perhaps hepatocellular carcinoma more so — inhibit immune cells that try to kill them,” said UC San Diego School of Medicine Professor Dan Kaufman, M.D., Ph.D., lead author on the study, director of the Sanford Advanced Therapy Center at the university’s Sanford Stem Cell Institute and Moores Cancer Center member.

“This is one key reason why some immunotherapies like CAR T cells have been less successful for solid tumors than for blood cancers — the immunosuppressive tumor microenvironment.”

Kaufman and his team produced stem cell-derived NK cells in which the receptor for transforming growth factor beta (TGF-β) — a protein that impairs immune function — was disabled. HCC tumors and the liver in general contain copious amounts of the substance, which both inhibits the immune cell activity and allows cancer to proliferate.

They found that typical NK cells without the disabled receptor, like CAR T cells, were not very effective in battling the cancer. “These are pretty resistant tumors — when we put them in mice, they grow and kill the mice,” he said. The five-year survival rate for HCC in humans is less than 20 percent. 

When researchers tested the modified NK cells against the cancer, however, “we got very good anti-tumor activity and significantly prolonged survival,” he noted.

“These studies demonstrate that it is crucial to block transforming growth factor beta — at least for NK cells, but I also think it’s true for CAR T cells,” Kaufman said. “If you unleash NK cells by blocking this inhibitory pathway, they should kill cancer quite nicely.”

Kaufman anticipates that his team’s discovery will manifest itself in the clinical trials of many research groups and companies — whether they’re working on CAR T-cell or NK-cell therapies, battling hepatocellular carcinoma or other challenging types of solid tumors.

“Anyone developing such therapies for solid tumors should be working to inhibit transforming growth factor beta activity to improve cancer-killing and attain effective anti-tumor activity,” he said.

Co-authors of this study include Jaya Lakshmi Thangaraj; Michael Coffey; and Edith Lopez, all of the Division of Regenerative Medicine at UC San Diego’s School of Medicine.

This work was made possible by the NIH/NCI grants U01CA217885, P30CA023100 (administrative supplement), and the Sanford Stem Cell Institute at the University of California San Diego.

About the Sanford Stem Cell Institute
The UC San Diego Sanford Stem Cell Institute (SSCI) is a global leader in regenerative medicine and a hub for stem cell science and innovation in space. SSCI aims to catalyze critical basic research discoveries, translational advances and clinical progress — terrestrially and in space — to develop and deliver novel therapeutics to patients.

# # #

END


ELSE PRESS RELEASES FROM THIS DATE:

Innovations in polyphenols research: Highlights from the upcoming 17th Annual 2024 World Congress in Milan

Innovations in polyphenols research: Highlights from the upcoming 17th Annual 2024 World Congress in Milan
2024-07-09
The 17th World Congress on Polyphenols Applications, taking place on September 19-20, 2024, at Università degli Studi di Milano Statale in Milan, Italy, will gather more than 140 attendees coming from 30+ countries. More than 20 international speakers will cover the latest advances in polyphenols research and their practical applications. Key Topics Polyphenols Applications 2024 will cover a wide range of topics, including the challenges in demonstrating the health benefits of polyphenols, the ...

Groundbreaking study reveals oceanic seabirds chase tropical cyclones

Groundbreaking study reveals oceanic seabirds chase tropical cyclones
2024-07-09
A new study published today in Current Biology, "Oceanic Seabirds Chase Tropical Cyclones," reveals that the rare Desertas Petrels (Pterodroma deserta), a wide-ranging seabird in the North Atlantic, exhibit unique foraging behaviors during hurricane season. Contrary to other pelagic seabirds, these petrels do not avoid intense tropical cyclones but instead exploit the dynamic conditions for their benefit, providing new insights into the impact of cyclones on open ocean marine life. "Initial studies suggested that seabirds either circumnavigate cyclones or seek refuge in the calm eye of the storm. However, the Desertas Petrels we tracked did neither; instead, one-third of ...

Study examines tree adaptability to climate change

Study examines tree adaptability to climate change
2024-07-09
During his recent yearlong sabbatical, Daniel Laughlin led a study that found trees can sustain life in temperatures higher or lower than where they are currently growing. While tree species appear to prefer distinct climatic conditions, the true nature of these preferences is obscured by species interactions and dispersal, which limit tree species’ ranges. “We were amazed. The result was crystal clear, and that doesn’t always happen in ecology,” says Laughlin, a professor in the University of Wyoming Department of Botany. “We found that tree species could grow and survive at one common moderate temperature, even though many ...

Advocate Health champions health equity through new, innovative dementia care model  

2024-07-09
CHARLOTTE, N.C. – Advocate Health has been selected by the Centers for Medicare and Medicaid Services (CMS) to participate in the Guiding an Improved Dementia Experience (GUIDE) Model, aimed to support advanced dementia patients and their caregivers in bridging the gaps associated with inequalities in dementia care. Following years of neurocognitive disorders research pioneered by Advocate Health's academic core,  Wake Forest University School of Medicine,  patients across the health system’s footprint now will benefit from the GUIDE Model’s new standardized approach to care for patients with dementia and their caregivers. Only 400 health organizations ...

Study points at novel approach to treat Group 3 medulloblastoma

2024-07-09
A team of researchers at Baylor College of Medicine, Texas Children’s Hospital, the Hospital for Sick Children in Toronto and collaborating institutions has identified and located a population of stem-like cells that initiates and maintains Group 3 medulloblastoma (Gr3-MB) in the developing brain. Gr3-MB is one of the most aggressive forms of brain cancer in children and is associated with metastatic spread and poor survival. The researchers showed that eliminating the small population of stem-like ...

Could a dietary fiber supplement offer long-awaited treatment for food allergy sufferers?

2024-07-09
A study from the University of Michigan has identified a potential new treatment for food allergies in inulin, a naturally occurring plant fiber commonly used as a supplement, a prebiotic in soda, a replacement for sweeteners and for other products and purposes.   In what appears to be a major advancement that offers the promise of relief to food allergy sufferers around the world, the paper published in Nature Materials describes inulin gel-based oral immunotherapy's success in stopping allergic reactions in mice by, in part, targeting bacteria in the gut. The gel prevented severe allergic reactions ...

The new paradigm in volunteering -- and how organizations can adapt to "neither-growing-nor-fading" brand relationships

2024-07-09
Researchers from Emlyon Business School and HEC Montreal published a new Journal of Marketing study that examines the new breed of volunteers who often show a weaker sense of affiliation with organizations and how best to engage them for mutual benefit. The study, forthcoming in the Journal of Marketing, is titled “Managing Brand Relationship Plurality: Insights from the Nonprofit Sector” and is authored by Verena Gruber and Jonathan Deschênes. Volunteers stand as vital pillars in the operation and survival of nonprofit organizations. Across ...

From empowering women to being empowered by women: A gendered social innovation framework for tourism-led development initiatives

From empowering women to being empowered by women: A gendered social innovation framework for tourism-led development initiatives
2024-07-09
Gendered Social Innovation: Social Change and Female Entrepreneurship in Tourism  Gendered social innovation is a crucial process that intertwines social change with female entrepreneurship, empowerment, and the evolution of work among women in the tourism industry.  Questioning Common Perceptions  Why question the usual perceptions about the role and status of women entrepreneurs in a globalized and capitalist industry? Where does power, creativity, and innovation truly reside in tourism development?  Often, discussions about gender equality in tourism revolve around a vision that confines women to the role of service providers, perpetuating stereotypes ...

Survey finds most women with uterine fibroids are offered hysterectomies over minimally invasive treatments

2024-07-09
FAIRFAX, Va. (July 9, 2024)— Among women who have personally been diagnosed with uterine fibroids, more than half (53%) were presented with a hysterectomy, while fewer than 1 in 5 (20%) were presented with other less invasive options such as over-the-counter NSAIDs (19%), uterine fibroid embolization (17%), oral contraceptives (17%), and endometrial ablation (17%), according to new survey data by The Harris Poll on behalf of the Society of Interventional Radiology. Moreover, some women (17%) mistakenly ...

Patient out-of-pocket costs for type 2 diabetes medications when aging into Medicare

2024-07-09
About The Study: In this cohort study of individuals with type 2 diabetes (T2D), the increase in spending upon reaching age 65 (when most people enroll in Medicare) was associated with patient coinsurance in the coverage gap and catastrophic coverage phases of Medicare Part D. The increased patient cost burden at age 65 and a modest reduction in overall T2D drug utilization suggest that as people with T2D age into Medicare, there is potentially an increase in nonadherence and diabetes complications.  Corresponding Author: To contact the corresponding author, Douglas ...

LAST 30 PRESS RELEASES:

The research was wrong: study shows moderate drinking won’t lengthen your life

Save your data on printable magnetic devices? New laser technique’s twist might make this reality

Early onset dementia more common than previously reported – the incidence of Alzheimer’s disease seems to be on the rise

Pesticides potentially as bad as smoking for increased risk in certain cancers

NUS researchers develop new battery-free technology to power electronic devices using ambient radiofrequency signals

New protein discovery may influence future cancer treatment

Timing matters: Scripps Research study shows ways to improve health alerts

New gene therapy approach shows promise for Duchenne muscular dystrophy

Chemical analyses find hidden elements from renaissance astronomer Tycho Brahe’s alchemy laboratory

Pacific Northwest launches clean hydrogen energy hub

Tiny deletion in heart muscle protein briefly affects embryonic ventricles but has long-term effects on adult atrial fibrillation

Harms of prescribing NSAIDs to high risk groups estimated to cost NHS £31m over 10 years

Wearing a face mask in public spaces cuts risk of common respiratory symptoms, suggests Norway study

Some private biobanks overinflating the value of umbilical cord blood banking in marketing to expectant parents

New research in fatty liver disease aims to help with early intervention

Genetics reveal ancient trade routes and path to domestication of the Four Corners potato

SNIS 2024: New study shows critical improvements in treating rare eye cancer in children

Wearable devices can increase health anxiety. Could they adversely affect health?

Addressing wounds of war

Rice researchers develop innovative battery recycling method

It’s got praying mantis eyes

Stroke recovery: It’s in the genes

Foam fluidics showcase Rice lab’s creative approach to circuit design

Montana State scientists publish evidence for new groups of methane-producing organisms

Daily rhythms depend on receptor density in biological clock

New England Journal of Medicine publishes outcomes from practice-changing E1910 trial for patients with BCR::ABL1-negative B-cell precursor acute lymphoblastic leukemia

Older adults want to cut back on medication, but study shows need for caution

Nationwide flood models poorly capture risks to households and properties

Does your body composition affect your risk of dementia or Parkinson’s?

Researchers discover faster, more energy-efficient way to manufacture an industrially important chemical

[Press-News.org] Stem cell-derived therapy shows promise against treatment-resistant liver cancer
New findings can be applied to NK cells — an under-appreciated part of the immune system — as well as CAR T cells, improving both therapies for multiple solid tumor types